Live Breaking News & Updates on Endometrial Cancer|Page 3

Stay updated with breaking news from Endometrial cancer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dostarlimab/Chemo Receives FDA Priority Review for Expanded Indication in Endometrial Cancer

The FDA has granted priority review to dostarlimab plus chemotherapy for all adult patients with primary advanced or recurrent endometrial cancer. ....

Prescription Drug User Fee Act , Endometrial Cancer , Priority Review ,